Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ADC3680
print preview
bookmark
share with colleague
General Information
Company
Pulmagen Therapeutics Ltd.
Description
Oral, small molecule prostaglandin D2 (PGD2) receptor (CRTH2) antagonist
Molecular Target
Prostaglandin D2 (PGD2) receptor (CRTH2) (GPR44) (CD294)
Mechanism of Action
Prostaglandin D2 (PGD2) receptor (CRTH2) antagonist
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy